Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Experimental cancer shot trial halted after just two patients

NCT ID NCT04387071

First seen Feb 23, 2026 · Last updated May 24, 2026 · Updated 11 times

Summary

This early-stage trial tested two immune-boosting drugs injected directly into tumors for people with stage IV pancreatic cancer or other advanced solid tumors (excluding melanoma). The goal was to see if the combination could shrink tumors or slow their growth. However, the study was terminated early after enrolling only 2 participants, so no conclusions about effectiveness could be drawn.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for UNRESECTABLE MALIGNANT SOLID NEOPLASM are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Hoag Memorial Hospital

    Newport Beach, California, 92663, United States

  • HonorHealth Research Institute

    Scottsdale, Arizona, 85258, United States

  • Lucile Packard Children's Hospital Stanford University

    Palo Alto, California, 94304, United States

  • USC / Norris Comprehensive Cancer Center

    Los Angeles, California, 90033, United States

Conditions

Explore the condition pages connected to this study.